0

NeuroKaire To Showcase Breakthrough Blood Test That Ends the Antidepressant Guessing Game at HLTH 2026 Conference

Company leverages patient-derived neurons and AI to support antidepressant choiceKEARNY, N.J. and TEL AVIV, Israel, Nov. 15, 2026 (GLOBE NEWSWIRE) -- NeuroKaire, turning a simple blood draw into a window on each patient’s brain, today announced its participation at the HLTH 2026 Conference taking p...